Clinical study on the treatment of acute cerebral infarction of wind phlegm stasis type with modified Banxia Baizhu Tianma tang combined with butylphthalein
半夏白术天麻汤加减联合丁苯酞治疗风痰瘀阻型急性脑梗死的临床研究

摘要

目的 探讨风痰淤阻型急性脑梗死患者临床治疗中使用半夏白术天麻汤加减联合丁苯酞的临床效果。方法 选取2022.10-2023.10我院收治的风痰淤阻型急性脑梗死患者88例，按照治疗方式分为对照组（丁苯酞治疗）和观察组（加用半夏白术天麻汤）各44例，对比两组治疗效果。结果 治疗前两组患者血液流变学指标和中医症候积分差异无统计学意义（P＞0.05），干预后观察组患者血液流变学指标均优于对照组，且中医症候积分低于对照组，差异均有统计学意义（P＜0.05）。结论 临床中治疗风痰淤阻型急性脑梗死患者使用半夏白术天麻汤加减联合丁苯酞治疗能够显著改善患者血液流变学情况，减轻临床症状，促进康复，具有较高应用价值。

Abstract

Objective: To explore the clinical effect of using modified Banxia Baizhu Tianma Tang combined with butylphthalide in the treatment of acute cerebral infarction patients with wind phlegm stasis type. Method: 88 patients with acute cerebral infarction of wind phlegm stasis type admitted to our hospital from October 2022 to October 2023 were selected. They were divided into a control group (treated with butylphthalide) and an observation group (treated with Banxia Baizhu Tianma Tang) according to the treatment method, with 44 cases in each group. The treatment effects of the two groups were compared. Result: There was no statistically significant difference in hemorheological indicators and traditional Chinese medicine syndrome score between the two groups of patients before treatment (P>0.05). After intervention, the hemorheological indicators of the observation group were better than those of the control group, and the traditional Chinese medicine syndrome score was lower than that of the control group, with statistical significance (P<0.05).
Conclusion  : The use of modified Banxia Baizhu Tianma Tang combined with butylphthalide in the treatment of acute cerebral infarction patients with wind phlegm stasis type in clinical practice can significantly improve the patient's blood rheology, alleviate clinical symptoms, promote rehabilitation, and has high application value.